MTHFR 基因多态性与非霍奇金淋巴瘤风险的关系:来自 31 篇文章的证据。

IF 3.3 3区 医学 Q2 ONCOLOGY
Journal of Cancer Pub Date : 2024-08-13 eCollection Date: 2024-01-01 DOI:10.7150/jca.99351
Gang Wang, Yuluo Wu, Zuolei Jing, Ruiting Wen, Yuanrui Song, Yin Feng, Guangru Li, Xiaopeng Zou, Gaoxiang Huang, Zhirong Jia, Yunmiao Guo, Zhigang Yang
{"title":"MTHFR 基因多态性与非霍奇金淋巴瘤风险的关系:来自 31 篇文章的证据。","authors":"Gang Wang, Yuluo Wu, Zuolei Jing, Ruiting Wen, Yuanrui Song, Yin Feng, Guangru Li, Xiaopeng Zou, Gaoxiang Huang, Zhirong Jia, Yunmiao Guo, Zhigang Yang","doi":"10.7150/jca.99351","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> <i>Methylenetetrahydrofolate reductase</i> (<i>MTHFR</i>) gene polymorphisms, particularly C677T and A1298C, have been implicated in various cancers, including non-Hodgkin lymphoma (NHL); however, their association with NHL risk remains inconclusive. <b>Methods:</b> We conducted an updated meta-analysis to assess the relationship between <i>MTHFR</i> gene polymorphisms (C677T and A1298C) and NHL risk. Relevant studies were identified through systematic literature searches in multiple databases. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to evaluate the strength of the associations. <b>Results:</b> The meta-analysis included 32 studies (8222 cases vs. 12956 controls) for <i>MTHFR</i> C677T and 26 studies (6930 cases vs. 11611 controls) for the A1298C polymorphism. Our meta-analysis revealed no significant associations between <i>MTHFR</i> gene polymorphisms (C677T and A1298C) and NHL risk. However, subgroup analysis stratified by ethnicity and NHL subtype yielded interesting findings for the C677T polymorphism. Specifically, in the subgroup analysis of Caucasians, the C677T polymorphism was significantly associated with NHL risk (heterozygous: OR=1.16, 95% CI=1.02-1.32; allele comparison: OR=1.07, 95% CI=1.01-1.13). Furthermore, in the analysis stratified by NHL subtype, the C677T polymorphism was significantly associated with increased follicular lymphoma (FL) risk (homozygous: OR=1.25, 95% CI=1.02-1.53; recessive: OR=1.28, 95% CI=1.06-1.56). False-positive result possibility (FPRP) analysis verified that the association of the <i>MTHFR</i> C677T polymorphism with NHL risk for Caucasians and FL subtypes was a true positive and deserves attention. We also determined that the C677T polymorphism is an expression quantitative trait locus (eQTL) since it is associated with <i>MTHFR</i> gene expression. <b>Conclusion:</b> There was no overall association between <i>MTHFR</i> gene polymorphisms (C677T and A1298C) and NHL risk, but stratified analyses revealed significant associations in specific subgroups. While meta-analyses inherently build upon existing studies, our work distinguishes itself by incorporating recent data, applying rigorous analytical techniques, and providing more evidence of the <i>MTHFR</i> C677T polymorphism as an eQTL.</p>","PeriodicalId":15183,"journal":{"name":"Journal of Cancer","volume":null,"pages":null},"PeriodicalIF":3.3000,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11375544/pdf/","citationCount":"0","resultStr":"{\"title\":\"Association of <i>MTHFR</i> gene polymorphisms with non-Hodgkin lymphoma risk: Evidence from 31 articles.\",\"authors\":\"Gang Wang, Yuluo Wu, Zuolei Jing, Ruiting Wen, Yuanrui Song, Yin Feng, Guangru Li, Xiaopeng Zou, Gaoxiang Huang, Zhirong Jia, Yunmiao Guo, Zhigang Yang\",\"doi\":\"10.7150/jca.99351\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background:</b> <i>Methylenetetrahydrofolate reductase</i> (<i>MTHFR</i>) gene polymorphisms, particularly C677T and A1298C, have been implicated in various cancers, including non-Hodgkin lymphoma (NHL); however, their association with NHL risk remains inconclusive. <b>Methods:</b> We conducted an updated meta-analysis to assess the relationship between <i>MTHFR</i> gene polymorphisms (C677T and A1298C) and NHL risk. Relevant studies were identified through systematic literature searches in multiple databases. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to evaluate the strength of the associations. <b>Results:</b> The meta-analysis included 32 studies (8222 cases vs. 12956 controls) for <i>MTHFR</i> C677T and 26 studies (6930 cases vs. 11611 controls) for the A1298C polymorphism. Our meta-analysis revealed no significant associations between <i>MTHFR</i> gene polymorphisms (C677T and A1298C) and NHL risk. However, subgroup analysis stratified by ethnicity and NHL subtype yielded interesting findings for the C677T polymorphism. Specifically, in the subgroup analysis of Caucasians, the C677T polymorphism was significantly associated with NHL risk (heterozygous: OR=1.16, 95% CI=1.02-1.32; allele comparison: OR=1.07, 95% CI=1.01-1.13). Furthermore, in the analysis stratified by NHL subtype, the C677T polymorphism was significantly associated with increased follicular lymphoma (FL) risk (homozygous: OR=1.25, 95% CI=1.02-1.53; recessive: OR=1.28, 95% CI=1.06-1.56). False-positive result possibility (FPRP) analysis verified that the association of the <i>MTHFR</i> C677T polymorphism with NHL risk for Caucasians and FL subtypes was a true positive and deserves attention. We also determined that the C677T polymorphism is an expression quantitative trait locus (eQTL) since it is associated with <i>MTHFR</i> gene expression. <b>Conclusion:</b> There was no overall association between <i>MTHFR</i> gene polymorphisms (C677T and A1298C) and NHL risk, but stratified analyses revealed significant associations in specific subgroups. While meta-analyses inherently build upon existing studies, our work distinguishes itself by incorporating recent data, applying rigorous analytical techniques, and providing more evidence of the <i>MTHFR</i> C677T polymorphism as an eQTL.</p>\",\"PeriodicalId\":15183,\"journal\":{\"name\":\"Journal of Cancer\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2024-08-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11375544/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.7150/jca.99351\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7150/jca.99351","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:亚甲基四氢叶酸还原酶(MTHFR)基因多态性,尤其是 C677T 和 A1298C,已被认为与包括非霍奇金淋巴瘤(NHL)在内的多种癌症有关;然而,它们与 NHL 风险的关系仍无定论。研究方法我们进行了一项最新的荟萃分析,以评估 MTHFR 基因多态性(C677T 和 A1298C)与 NHL 风险之间的关系。通过在多个数据库中进行系统性文献检索,确定了相关研究。计算了汇总的几率比(ORs)和 95% 的置信区间(CIs),以评估相关性的强度。结果荟萃分析包括 32 项关于 MTHFR C677T 的研究(8222 例病例与 12956 例对照)和 26 项关于 A1298C 多态性的研究(6930 例病例与 11611 例对照)。我们的荟萃分析表明,MTHFR基因多态性(C677T和A1298C)与NHL风险之间没有明显的关联。然而,按种族和 NHL 亚型进行的亚组分析对 C677T 多态性产生了有趣的发现。具体来说,在白种人亚组分析中,C677T 多态性与 NHL 风险显著相关(杂合子:OR=1.16,95% NHL:A1298C):OR=1.16,95% CI=1.02-1.32;等位基因比较:OR=1.07,95% CI=1.01-1.13)。此外,在按 NHL 亚型分层的分析中,C677T 多态性与滤泡性淋巴瘤(FL)风险增加显著相关(同基因:OR=1.25,95% CI=1.02-1.53;隐性:OR=1.28,95% CI=1.06-1.56)。假阳性结果可能性(FPRP)分析证实,白种人和 FL 亚型的 MTHFR C677T 多态性与 NHL 风险的相关性为真阳性,值得关注。我们还确定,C677T 多态性是一个表达定量性状位点(eQTL),因为它与 MTHFR 基因的表达有关。结论MTHFR基因多态性(C677T和A1298C)与NHL风险之间没有整体关联,但分层分析显示在特定亚组中存在显著关联。虽然荟萃分析本质上是建立在现有研究的基础上,但我们的工作与众不同,它纳入了最新数据,应用了严格的分析技术,并提供了更多证据证明 MTHFR C677T 多态性是一种 eQTL。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Association of MTHFR gene polymorphisms with non-Hodgkin lymphoma risk: Evidence from 31 articles.

Background: Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms, particularly C677T and A1298C, have been implicated in various cancers, including non-Hodgkin lymphoma (NHL); however, their association with NHL risk remains inconclusive. Methods: We conducted an updated meta-analysis to assess the relationship between MTHFR gene polymorphisms (C677T and A1298C) and NHL risk. Relevant studies were identified through systematic literature searches in multiple databases. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to evaluate the strength of the associations. Results: The meta-analysis included 32 studies (8222 cases vs. 12956 controls) for MTHFR C677T and 26 studies (6930 cases vs. 11611 controls) for the A1298C polymorphism. Our meta-analysis revealed no significant associations between MTHFR gene polymorphisms (C677T and A1298C) and NHL risk. However, subgroup analysis stratified by ethnicity and NHL subtype yielded interesting findings for the C677T polymorphism. Specifically, in the subgroup analysis of Caucasians, the C677T polymorphism was significantly associated with NHL risk (heterozygous: OR=1.16, 95% CI=1.02-1.32; allele comparison: OR=1.07, 95% CI=1.01-1.13). Furthermore, in the analysis stratified by NHL subtype, the C677T polymorphism was significantly associated with increased follicular lymphoma (FL) risk (homozygous: OR=1.25, 95% CI=1.02-1.53; recessive: OR=1.28, 95% CI=1.06-1.56). False-positive result possibility (FPRP) analysis verified that the association of the MTHFR C677T polymorphism with NHL risk for Caucasians and FL subtypes was a true positive and deserves attention. We also determined that the C677T polymorphism is an expression quantitative trait locus (eQTL) since it is associated with MTHFR gene expression. Conclusion: There was no overall association between MTHFR gene polymorphisms (C677T and A1298C) and NHL risk, but stratified analyses revealed significant associations in specific subgroups. While meta-analyses inherently build upon existing studies, our work distinguishes itself by incorporating recent data, applying rigorous analytical techniques, and providing more evidence of the MTHFR C677T polymorphism as an eQTL.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Cancer
Journal of Cancer ONCOLOGY-
CiteScore
8.10
自引率
2.60%
发文量
333
审稿时长
12 weeks
期刊介绍: Journal of Cancer is an open access, peer-reviewed journal with broad scope covering all areas of cancer research, especially novel concepts, new methods, new regimens, new therapeutic agents, and alternative approaches for early detection and intervention of cancer. The Journal is supported by an international editorial board consisting of a distinguished team of cancer researchers. Journal of Cancer aims at rapid publication of high quality results in cancer research while maintaining rigorous peer-review process.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信